Menu
GWAS Study

ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma.

Praveen K, Patel GC, Gurski L et al.

36192519 PubMed ID
GWAS Study Type
129207 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

PK
Praveen K
PG
Patel GC
GL
Gurski L
AA
Ayer AH
PT
Persaud T
SM
Still MD
ML
Miloscio L
VZ
Van Zyl T
DG
Di Gioia SA
BB
Brumpton B
KK
Krebs K
ÅB
Åsvold BO
CE
Chen E
CV
Chavali VRM
FW
Fury W
GH
Gudiseva HV
HS
Hyde S
JE
Jorgenson E
LS
Lefebvre S
LD
Li D
LA
Li A
MJ
Mclninch J
PB
Patel B
RJ
Rabinowitz JS
SR
Salowe R
SC
Schurmann C
SA
Seidelin AS
SE
Stahl E
SD
Sun D
TT
Teslovich TM
TA
Tybjærg-Hansen A
WC
Willer C
WS
Waldron S
WS
Walley S
YH
Yang H
ZS
Zaveri S
HY
Hu Y
HK
Hveem K
MO
Melander O
ML
Milani L
SS
Stender S
OJ
O'Brien JM
JM
Jones MB
AG
Abecasis GR
CM
Cantor MN
WJ
Weyne J
KK
Karalis K
EA
Economides A
DG
Della Gatta G
FM
Ferreira MA
YG
Yancopoulos GD
BA
Baras A
RC
Romano C
CG
Coppola G
Chapter II

Abstract

Summary of the research findings

Glaucoma is a leading cause of blindness. Current glaucoma medications work by lowering intraocular pressure (IOP), a risk factor for glaucoma, but most treatments do not directly target the pathological changes leading to increased IOP, which can manifest as medication resistance as disease progresses. To identify physiological modulators of IOP, we performed genome- and exome-wide association analysis in >129,000 individuals with IOP measurements and extended these findings to an analysis of glaucoma risk. We report the identification and functional characterization of rare coding variants (including loss-of-function variants) in ANGPTL7 associated with reduction in IOP and glaucoma protection. We validated the human genetics findings in mice by establishing that Angptl7 knockout mice have lower (~2 mmHg) basal IOP compared to wild-type, with a trend towards lower IOP also in heterozygotes. Conversely, increasing murine Angptl7 levels via injection into mouse eyes increases the IOP. We also show that acute Angptl7 silencing in adult mice lowers the IOP (~2-4 mmHg), reproducing the observations in knockout mice. Collectively, our data suggest that ANGPTL7 is important for IOP homeostasis and is amenable to therapeutic modulation to help maintain a healthy IOP that can prevent onset or slow the progression of glaucoma.

129,207 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

129207
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.